MedTrace Logo

Oslo Antioxidant Study

NCT00520819 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2007-08-27

No results posted yet for this study

Summary

The primary objective of this study is to test whether increasing the total intake of antioxidants to middle-aged smoking men increases the antioxidant defence, reduces oxidative damage, and improves biomarkers for oxidative stress.

The secondary objectives is to test whether this strategy improves other cardiovascular risk markers including platelet function, lipid levels, inflammation, and markers of endothelial damage.

Conditions

Interventions

DRUG

Antioxidant-rich food items

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER

  • University of Oslo

    lead OTHER

Principal Investigators

  • Rune Blomhoff, PhD · University of Oslo

  • Serena Tonstad, MD · Ullevaal University Hospital

  • Anette Karlsen, MSc · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-02-28
Completion
2005-03-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00520819 on ClinicalTrials.gov